Manufacturer: Biocon
Salt Composition : Itolizumab(25mg)
Alzumab 25mg Injection is given by your doctor or nurse, who will make sure you get the right amount. The dose you're given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your doctor know about all other medications you are taking as some may affect, or be affected by this medicine.
Itolizumab binds to CD6 which modulates T-lymphocyte activation and proliferation. It is an efficacious immunomodulatory compound investigated for treating psoriasis. Currently, the full mechanisms of action are still unclear. Improve decision support & research outcomes with our structured adverse effects data.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Alzumab
Infusion reaction
Upper respiratory tract infection
Fever
Itching
Infusion related reactions
Usage of this medicine may cause symptoms like fever, chills, nausea, vomiting, dizziness, dyspnea, fall in blood pressure, etc. in some patients. Appropriate symptomatic treatment, dose adjustments, or discontinuation of therapy may be necessary in these cases based on the clinical condition.
Infections
This medicine should be used with extreme caution in patients with a history of infections; it is not recommended for use in case of active infections due to the increased risk of worsening of the patient’s condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases.
Use in children
This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.
Alzumab 25mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
It is not known whether it is safe to consume alcohol with Alzumab 25mg Injection. Please consult your doctor.
Information regarding the use of Alzumab 25mg Injection during breastfeeding is not available. Please consult your doctor.
Itolizumab binds to CD6 which modulates T-lymphocyte activation and proliferation. It is an efficacious immunomodulatory compound investigated for treating psoriasis. Currently, the full mechanisms of action are still unclear. Improve decision support & research outcomes with our structured adverse effects data.
Drug-Disease Interaction: ITOLIZUMAB should be used with caution in cases of liver, heart or kidney diseases, bone marrow suppression, low blood cell count, weak immune system (HIV), neutropenia, lymphopenia, tuberculosis, hepatitis B, C, and active infections.
Kindly do not self administer.
Store below 30°C
Alzumab 25mg Injection is used in the treatment of psoriasis.
Keep a watch on any sign or symptom of new infection during and after the treatment with Alzumab 25mg Injection. Report immediately to your doctor.
Inform your doctor if you have any kidney or liver disease.
Inform your doctor if you are pregnant or breastfeeding.
Let your doctor know if you have any history of severe allergy.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
